Carl Dambkowski
Director at Oruka Therapeutics, Inc. (ORKA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.6M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 12SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 22,41751,326 held (−30%) | $70.13 | $1.6M | +17.1% |
| Jun 12SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 12,58338,743 held (−25%) | $70.11 | $882K | +17.1% |
| May 22SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 38,318140,425 held (−21%) | $58.43 | $2.2M | +40.5% |
| May 22SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 53,44786,978 held (−38%) | $59.10 | $3.2M | +38.9% |
| May 22SEC | ORKAOruka Therapeutics, Inc. | Sell Plan | 13,23573,743 held (−15%) | $59.97 | $794K | +36.9% |
- Sell
Director Carl Dambkowski sold $1.6M of ORKA at $70.13 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Carl Dambkowski sold $882K of ORKA at $70.11 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Carl Dambkowski sold $2.2M of ORKA at $58.43 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Carl Dambkowski sold $3.2M of ORKA at $59.10 — cuts the stake by 38%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Carl Dambkowski sold $794K of ORKA at $59.97 — pre-scheduled 10b5-1 plan sale.